Genetically modified plants expressing proteinase inhibitors, SaPIN2a or SaPIN2b, and methods of use thereof for the inhibition of trypsin-and chymotrypsin-like activities
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A01H-005/00
C12N-015/82
C12N-015/29
출원번호
US-0725829
(2003-12-01)
등록번호
US-7256327
(2007-08-14)
발명자
/ 주소
Chye,Mee Len
Xu,Zeng Fu
Sin,Suk Fong
출원인 / 주소
The University of Hong Kong
대리인 / 주소
Dickstein, Shapiro, LLP.
인용정보
피인용 횟수 :
0인용 특허 :
11
초록▼
The present invention relates to proteinase inhibitor II genes, SaPIN2a and SaPIN2b, their production in transformed plants, and isolation of SaPIN2a and SaPIN2b proteins from transformed plants of the invention. The invention further relates to use in inhibiting endogenous protease activities in tr
The present invention relates to proteinase inhibitor II genes, SaPIN2a and SaPIN2b, their production in transformed plants, and isolation of SaPIN2a and SaPIN2b proteins from transformed plants of the invention. The invention further relates to use in inhibiting endogenous protease activities in transformed plants. In specific embodiments, the protease activities are trypsin-like and chymotrypsin-like activities. The invention relates to a method for protection of heterologous protein production in transformed plants by the co-expression of a proteinase inhibitor gene, e.g. SaPIN2a or SaPIN2b, which encodes a proteinase inhibitor protein, or a biologically active fragment, analog, and variant thereof, that inhibits protease activities. Specifically, the present invention also provides methods of inhibiting programmed cell death, including senescence, in plants. The invention further relates to methods to enhance resistance of plants to pests or pathogens, including insects. The present invention also relates to genetically modified plants, and in particular genetically modified lettuce. The genetically modified plants have inhibited endogenous trypsin-like and chymotrypsin-like activities following transformation of the plant with a vector comprising one or more proteinase inhibitor II gene, such as SaPIN2a and/or SaPIN2b. The invention further relates to transformed plants having enhanced resistance to insects. The invention further relates to transformed plants in which PCD or senescense is inhibited by transformation of plants using vectors of the present invention.
대표청구항▼
What is claimed is: 1. An isolated proteinase inhibitor II nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO:1, or a nucleotide sequence that encodes the amino acid sequence of SEQ ID NO:2. 2. A method for producing a transformed plant comprising: (i) transforming a plant with
What is claimed is: 1. An isolated proteinase inhibitor II nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO:1, or a nucleotide sequence that encodes the amino acid sequence of SEQ ID NO:2. 2. A method for producing a transformed plant comprising: (i) transforming a plant with a polynucleotide that comprises the nucleotide sequence of SEQ ID NO:1 or encodes the amino acid sequence of SEQ ID NO:2; and (ii) selecting a transformed plant in which said nucleotide sequence is expressed. 3. The method of claim 2, wherein said transforming is by nuclear transformation. 4. The method of claim 2, wherein said transforming is by plastid transformation. 5. The method of any of claim 2, wherein an endogenous proteinase activity of the transformed plant is inhibited. 6. The method of claim 5, wherein the endogenous protease activity is a trypsin-like activity or chymotrypsin-like activity. 7. A method for inhibiting programmed cell death and senescence in a transformed plant or plant part comprising: (i) transforming a plant with a polynucleotide that comprises the nucleotide sequence of SEQ ID NO:1 or encodes the amino acid sequence of SEQ ID NO:2; and (ii) selecting a transformed plant in which said polynucleotide is expressed. 8. The method of claim 7, wherein said transforming is by nuclear transformation. 9. The method of claim 7, wherein said transforming is by plastid transformation. 10. The method of claim 7, wherein an endogenous proteinase activity of the transformed plant is inhibited. 11. The method of claim 10, wherein the endogenous proteinase activity is a trypsin-like activity or chymotrypsin-like activity. 12. A method for producing a heterologous protein in a plant comprising: (i) transforming a plant with a first polynucleotide that comprises the nucleotide sequence of SEQ ID NO:1, or encodes the amino acid sequence of SEQ ID NO:2; (ii) transforming the plant with a second polynucleotide that encodes a heterologous protein; and (iii) isolating said heterologous protein. 13. The method of claim 12, wherein said transforming is by nuclear transformation. 14. The method of claim 12, wherein said transforming is by plastid transformation. 15. A transformed plant produced by the steps of: (i) transforming a plant with a recombinant vector comprising a polynucleotide that comprises the nucleotide sequence of SEQ ID NO:1 or encodes the amino acid sequence of SEQ ID NO:2; and (ii) selecting a transformed plant in which said polynucleotide is expressed. 16. The transformed plant of claim 15, which is a transgenic plant. 17. The transformed plant of claim 15, which is a transplastomic plant. 18. A transformed plant comprising a polynucleotide that comprises the nucleotide sequence of SEQ ID NO:1 or encodes the amino acid sequence of SEQ ID NO:2. 19. The transformed plant of claim 18, which is a transgenic plant. 20. The transformed plant of claim 18, which is a transplastomic plant. 21. The transformed plant of any one of claims 15-17 or 18-20, wherein the plant is a leafy vegetable crop. 22. The transformed plant of claim 21, wherein the crop is lettuce. 23. The transformed plant of claim 22, wherein an endogenous proteinase activity of the transformed lettuce is inhibited. 24. The transformed plant of claim 23, wherein the endogenous proteinase activity is a trypsin-like activity or chymotrypsin-like activity. 25. A transgenic lettuce comprising cells that comprise pSa7. 26. A transplastomic tobacco comprising cells that comprise pMLVHisP. 27. A recombinant vector comprising: a polynucleotide that comprises the nucleotide sequence of SEQ ID NO:1 or encodes the amino acid sequence of SEQ ID NO:2. 28. The recombinant vector of claim 27, further comprising one or more regulatory elements operatively linked to said polynucleotide. 29. The recombinant vector of claim 28, wherein the regulatory element is 35S promoter of cauliflower mosaic virus (CaMV 35S). 30. A recombinant vector which is pSa7. 31. A recombinant vector which is pMLVHisP. 32. A recombinant cell comprising-the recombinant vector of claim 27. 33. The recombinant cell of claim 32, wherein the cell is a plant cell. 34. The recombinant cell of claim 33, wherein the plant cell is from a plant selected from the group consisting of tomatoes, ginger, scallions, water chestnuts, pepper, eggplant, lettuce, spinach, broccoli, brussels sprouts, calabrese, kale, cauliflower, red cabbage, white cabbage, cucumber, melon, watermelon, zucchini, squash, peas, beans, sweetcorn, carrots, onions, berries, grapes, banana, pineapple, rosaceous fruit and nut crops, tobacco, mango and papaya. 35. The recombinant cell of claim 33, wherein the plant cell is from a plant selected from the group consisting of Anacardium, Arachis, Asparagus, Atropa, Avena, Brassica, Citrus, Citrullus, Capsicum, Carthamus, Cocos, Coffea, Cucumis, Cucurbita, Daucus, Elaeis, Fragaria, Glycine, Gossypium, Helianthus, Heterocallis, Hordeum, Hyoscyamus, Lactuca, Linum, Lolium, Lupinus, Lycopersicon, Malus, Manihot, Majorana, Medicago, Nicotiana, Olea, Oryza, Panieum, Panneserum, Persea, Phaseolus, Pistachia, Pisum, Pyrus, Prunus, Raphanus, Ricinus, Secale, Senecio, Sinapis, Solanum, Sorghum, Theobromus, Trigonella, Titicum, Vicia, Vitis, Vigna, and Zea.
Gage Fred H. (La Jolla CA) Friedmann Theodore (La Jolla CA) Rosenberg Michael B. (San Diego CA) Wolff Jon A. (Madison WI) Schinstine Malcolm (San Diego CA) Kawaja Michael D. (Toronto CAX) Ray Jasodha, Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.